Abstract
Recent advances in the biology of colorectal polyposis may permit the evolution of strategies for the management of colorectal polyps. Molecular genetic studies have identified mutations in both inherited and sporadic polyps. Epidemiologic studies suggest personal habits and characteristics that may predispose individuals to higher risk of developing polyposis. Better understanding of the adenoma-to-carcinoma sequence suggests guidelines for screening, treatment, and follow-up. Research in the area of pharmacotherapy offers options for prevention and treatment. These advances may contribute to the reduction of morbidity and mortality from colorectal carcinoma.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
